IndusInd Bank Ltd.'s credibility and earnings will be impacted, say analysts, after the lender identified accounting discrepancies of 2.35% of the bank’s net worth as of December 2024 in its derivatives portfolio during an internal review. Several brokerages have reduced their target price for the bank's stock amid fresh turmoil.
The bank has appointed an external agency to review and validate its internal findings independently. The disclosure followed the Reserve Bank of India’s September 2023 guidelines on bond investment categorisation and valuation.
This will have an approximate impact of Rs 2,100 crore, the management said in an analyst call.
Such lapses reflects "weak internal controls" in the Mumbai-based private bank, said Jefferies.
The discrepancy has likely led to the overstatement of net interest income in the years prior to fiscal 2024. "This, along with shorter CEO term extension and challenges in MFI will limit rerating. We lower FY25 earnings estimate by 25%," the brokerage said.
Recent developments have raised the risk perception and impact disclosed borrowings cost too, Citi said in a note.
"Whether this process lapse is one rationale for RBI’s discomfort or there is more to it needs to be monitored," it said, referring to last week's decision by the banking regulator to allow only a one-year extension to Chief Executive Officer Sumant Kathpalia.
IndusInd Bank will face a "litmus test" from the succession viewpoint and the board is likely to evaluate both external as well as internal candidates, the brokerage said.
Analysts at Nuvama called the timeline of multiple negative events in FY25 "discomforting"—the CFO resigned just before the third-quarter earnings, the CEO got a shorter extension and now a derivatives-induced dislocation.
"A negative derivatives’ disclosure has the potential to unnerve investors more than a back-dated NPL disclosure," the brokerage said.
UBS estimates lower growth of 12% and credit costs to remain elevated at 1.5% next fiscal, as the bank has indicated additional provisioning which, coupled with higher slippages, will keep credit costs high over the next few quarters.
Emkay expects the IndusInd Bank stock to react adversely in the near term, to the recent events as well as to the elevated stress in MFI and hence remain under pressure.
IndusInd Bank Stock Rate Actions
Citi: Maintained 'buy' but target price cut from Rs 1,350 to Rs 1,160.
Nuvama: Downgraded to 'reduce' from 'hold' with the target price cut to Rs 750.
Emkay: Downgrade to 'add' from 'buy' with the target price reduced to Rs 875 from Rs 1,125.
Jefferies: Maintain 'buy' but target price slashed from Rs 1,080 to Rs 1,040.
Morgan Stanley: Maintain 'equal-weight'.
UBS: Maintain 'sell' with target price cut from Rs 850 to Rs 770.
IndusInd Bank's share price declined 10.14% to Rs 810.45 apiece, wiping off over Rs 7,100 crore in market value. This was the lowest level since July 2022. The stock was the top loser on the benchmark NSE Nifty 50, which was down 0.38%.
RECOMMENDED FOR YOU

Motilal Oswal Stays 'Neutral' On IndusInd Bank — Here's Why


'Buy' MCX Shares Maintains HDFC Securities, Hikes Target Price — Here's Why


'Buy' DCB Bank Shares Maintains ICICI Securities, Sees Upto 22% Upside — Here's Why


Stock Recommendations Today: HDFC Bank, IndusInd Bank, IndiGo On Brokerages' Radar
